BIOMOLECULAR IMAGING SYSTEM MARKET

INTRODUCTION

The structure of an enzyme class known as enoyl-CoA carboxylases/reductases is revealed via biomolecular imaging. These photosynthesis-related enzymes are incredibly efficient at removing carbon dioxide from the environment by fixing it.

It is now possible to see, characterise, and measure the biological processes occurring at the cellular and subcellular levels in intact living beings, including patients, thanks to the expanding biomedical research field known as molecular imaging (MI).

Molecular imaging procedures are used to diagnose and treat a variety of conditions, including cancer, heart disease, brain disorders like Alzheimer's and Parkinson's disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more. These procedures are noninvasive, safe, and painless. 

BIOMOLECULAR IMAGING SYSTEM MARKET SIZE AND FORECAST

The Global biomolecular imaging system market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

BIOMOLECULAR IMAGING SYSTEM MARKET NEW PRODUCT LAUNCH

New Molecular Imaging Systems Are Available From GE Healthcare, Supporting Quantitative Care and Research The Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2016 saw the introduction of new molecular imaging technologies from GE Healthcare that will allow doctors to provide patients with individualised, quantified data.

With the use of the Discovery MI system and Discovery NM/CT 670 CZT, physicians will be better able to direct patient care, provide sensitive support for patients, and foster an environment conducive to compelling research.

The future generation of molecular imaging systems are represented by both systems' cutting-edge, innovative digital detectors. The new nuclear medicine workstation, XelerisTM 4.0, supports the Discovery NM/CT 670 CZT as well as other nuclear medicine systems.

With its quantitative applications, Xeleris 4.0 gives clinicians greater confidence in their ability to customise and easily read reports for a variety of care settings.

Discovery MI was developed to support doctors in their ongoing attempts to stage diseases early, diagnose patients, and better direct treatment methods. It also enables more compelling research using a wider variety of innovative, quickly degrading tracers.

The only PET/CT system in the market, Discovery MI combines the most cutting-edge reconstruction technology—the union of Time-of-Flight (TOF) and Q.Clear—with the sensitivity of digital detection. Outstanding resolution improves the ability to find small lesions as a result.

Due to the system's wider range of view, clinicians will be able to conduct more interesting research, such as quantitative brain tests (FOV).

Discovery MI may also broaden the range of diagnostic services that doctors may provide by improving their cancer clinical expertise or by pushing the limits of PET in areas such as neurology, cardiology, and other fields. These increased powers

BIOMOLECULAR IMAGING SYSTEM MARKET COMPANY PROFILES

• GE Healthcare
• Molecular
• Shimadzu
• MILABS
• United Imaging 

THIS BIOMOLECULAR IMAGING SYSTEM MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Biomolecular imaging systems are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Biomolecular imaging system and key vendor selection criteria
3. Where is the Biomolecular imaging system manufactured? What is the average margin per unit?
4. Market share of Global Biomolecular imaging system market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Biomolecular imaging system in-house
6. key predictions for next 5 years in Global Biomolecular imaging system market
7. Average B-2-B Biomolecular imaging system market price in all segments
8. Latest trends in Biomolecular imaging system market, by every market segment
9. The market size (both volume and value) of the Biomolecular imaging system market in 2024-2030 and every year in between?
10. Production breakup of Biomolecular imaging system market, by suppliers and their OEM relationship